Bausch & Lomb

Valeant to acquire Bausch & Lomb for $8.7 bn

27 May 2013

Valeant Pharmaceuticals International  today said that it will buy out global eye care major Bausch & Lomb Holdings Inc for $8.7 billion in cash from PE firm Warburg Pincus

Canada’s Valeant in talks to buy Bausch & Lomb for $9 bn

25 May 2013

After abandoning its $13 billion cash and stock bid for generic drug giant Actavis, Valeant, one of the most acquisitive pharmaceutical companies, has identified on Bausch and Lomb to strengthen its visual-care products

US eye care firm Bausch & Lomb files for IPO

23 Mar 2013

Warburg Pincus seeks $10 bn plus for eye care company Bausch & Lomb

12 Dec 2012

Bausch & Lomb to acquire Ista Pharmaceuticals for $500 million

27 Mar 2012

Advanced Medical outbids Warburg Pincus with $4.23 billion offer for Bausch & Lomb

By Our Corporate Bureau | 07 Jul 2007

Free lens from Bausch & Lomb

By Our Corporate Bureau | 27 Jan 2005

Bausch & Lomb launches Zyoptix 100

By Venkatachari Jagannathan | 27 Jan 2004

Bhai Manjit Singh exits Bausch & Lomb

By Ananth Iyer | 22 May 1999